Skip to content

Effects of Esomeprazole on Postoperative Nausea and Vomiting in Female Patients Undergoing Thyroid Surgery

Effects of Esomeprazole on Postoperative Nausea and Vomiting in Female Patients Undergoing Thyroid Surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107719
Enrollment
Unknown
Registered
2025-08-18
Start date
2025-08-25
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting

Interventions

Esomeprazole group:30 minutes before anesthesia induction, 40mg of esomeprazole was administered intravenously for 3 minutes (add 1 bottle of 40mg of esomeprazole freeze-dried powder to 5mL of normal
Control group :Give 5ml of normal saline by intravenous injection for 3 minutes 30 minutes before anesthesia induction.

Sponsors

Department of anesthesiology, the First Affilitated hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-65 years old; 2. BMI: 18-30 kg/m²; 3. ASA I-III grade; 4. Female patients who plan to undergo elective thyroidectomy under general anesthesia; 5. History of motion sickness or PONV; 6. No gastrointestinal diseases, and no gastrointestinal surgeries have been performed except for simple cholecystectomy; 7. Communication and interaction are normal; 8. Take the test voluntarily and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Allergic to esomeprazole; 2. Take antiemetic or analgesic drugs within 24 hours before the operation; 3. Use H2 receptor inhibitors and PPIs; 4. Use drugs that interact with esomeprazole (such as phenytoin, diazepam, ketoconazole, itraconazole, warfarin/vitamin K antagonists, clopidogrel, etc.); 5. Use of antipsychotic drugs or corticosteroid drugs; 6. Previous heart failure or arrhythmia; Uncontrolled hypertension Diabetes mellitus with poor blood sugar control; Liver and kidney dysfunction; Gastric motility disorder Vestibular disorders; 7. Pregnant or lactating women; 8. Inability to understand the Postoperative Quality of Recovery Scale (QoR-15)/Visual Analogue Scale (VAS).

Design outcomes

Primary

MeasureTime frame
Incidence of nausea and vomiting 24 hours after surgery;

Secondary

MeasureTime frame
Visual Analogue Scale pain score ;Ramsay sedation score ;PONV impact scale;Quality of recovery-15 items;Incidence of nausea and vomiting 1 hour and 6 hours after surgery;Use of remedial antiemetics and remedial analgesics;PACU residence time;time of first exhaust;time of first defecation;hospital stays;Whether opioid drugs are used after the operation;The number of users and dosage of vasoactive drugs;The number of users and dosage of neostigmine;

Countries

China

Contacts

Public ContactLu Yao

Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University

luyao-mz@163.com+86 189 5656 4060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026